SCHEMBL4740442

SCHEMBL4740442

Cc1ccc(F)c(N(C(N)=O)c2ccc(-c3cccc4[nH]nc(N)c34)cc2F)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 15/20 0.81
▸ FLT3 P36888 9/20 0.57
▸ KIT P10721 8/20 0.57
▸ FLT1 P17948 8/20 0.57
▸ ABL1 P00519 8/20 0.57
▸ FLT4 P35916 7/20 0.57
▸ CSF1R P07333 7/20 0.57
▸ LYN P07948 5/20 0.57
▸ SRC P12931 5/20 0.57
▸ BLK P51451 5/20 0.57
▸ RET P07949 4/20 0.57
▸ FGFR1 P11362 4/20 0.57
▸ PRKACA P17612 4/20 0.57
▸ MAP4K2 Q12851 4/20 0.57
▸ ROCK1 Q13464 4/20 0.57
▸ CLK4 Q9HAZ1 4/20 0.57
▸ NTRK1 P04629 4/20 0.57
▸ CDK19 Q9BWU1 3/20 0.57
▸ PLK4 O00444 3/20 0.57
▸ AURKA O14965 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426417 0.90 KDR (1.00) KDRFLT3KITFLT1ABL1
SCHEMBL29923459 0.90 KDR (1.00) KDRFLT3KITFLT1ABL1
Water SCHEMBL15475146 0.89 KDR (0.98) KDRFLT3KITFLT1ABL1
SCHEMBL13372706 0.89 KDR (0.64) KDRFLT3KITFLT1ABL1
Alcohol SCHEMBL16817143 0.87 KDR (0.94) KDRFLT3KITFLT1ABL1
SCHEMBL27636400 0.87 KDR (0.62) KDRFLT3KITFLT1ABL1
SCHEMBL27636422 0.83 KDR (0.64) KDRFLT3KITFLT1ABL1
SCHEMBL27636446 0.83 KDR (0.64) KDRFLT3KITFLT1ABL1
SCHEMBL27657307 0.82 KDR (0.66) KDRFLT3KITFLT1ABL1
SCHEMBL28757592 0.81 KDR (0.61) KDRFLT3KITFLT1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008080110-A1 METHODS FOR TREATING MACULAR EDEMA AND PATHOLOGIC OCULAR ANGIOGENESIS USING A NEUROPROTECTIVE AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR ALCON, INC. (CH) 2008-07-03 — — WO disclosed
Send feedback